Skip to main content
This R&D Website is for US Healthcare Professionals Only

Clinical Trials

In order to address significant unmet medical needs, AbbVie aims to expedite the clinical development process for oncology treatments through the use of streamlined clinical trial designs that utilize biochemical markers, imaging technologies and definitive, profound clinical endpoints. Below is a select list of some of our active clinical trials.

Investigational drugs mentioned are for use in clinical studies only, and may be studied alone or in combination with drugs for indications that have not been approved by the FDA. Approved drugs mentioned are also being studied for uses for which they are not approved.

Safety and efficacy have not been established for any of these drugs for the uses being studied. AbbVie in no way intends to recommend or imply that these drugs should be used for unapproved uses.

Filter

View By:
Product/Compound
Cancer Type
Cancer Type:
Hematologic Malignancies
Lung Cancer
Brain Cancer
Breast Cancer
Solid Tumor
Ovarian Cancer
Clear All Filters
Phase:
Phase 1 Ph 1
Phase 2 Ph 2
Phase 3 Ph 3
CS1
EGFR
PI3K
PARP
BCL-2
elotuzumab
veliparib
duvelisib
ibrutinib
ABT-414
ABT-888
ABBV-221
ABBV-075
rovalpituzumab-tesirine
Filter Selection:

Based on the selected filters, there are no results matching your criteria. Please reduce the number of filters selected or clear all to broaden your search. You may also visit clinicaltrials.gov to request additional information.

Veliparib

How to Participate

For information about becoming an investigator or enrolling patients in clinical trials, please submit an information request through AbbVieMedInfo.com.

Go to AbbVieMedInfo.com

Compassionate Use

Learn more about our policy regarding access to investigational drugs. Read our full statement and FAQs on our corporate website.

Go to AbbVie.com